Rituximab for Management of Refractory Pregnancy-Associated Immune Thrombocytopenic Purpura

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 12, 2010, Pages 1167-1171

  Gall, Brent ^a   Yee, Adrian ^a   Berry, Brian ^a   Bircham, Deborah ^a   Hayashi, Allen ^a   Dansereau, Jerome ^a   Hart, Jason ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

ITP; Pregnancy; Rituximab; Turner's syndrome

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN; PREDNISONE; RITUXIMAB; TRANEXAMIC ACID; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ANEMIA; APGAR SCORE; ARTICLE; B LYMPHOCYTE; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPOGLYCEMIA; HYPONATREMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAUTERINE GROWTH RETARDATION; LYMPHOCYTE COUNT; MELENA; NEONATAL HYPERBILIRUBINEMIA; NEWBORN; OPERATIVE BLOOD LOSS; ORAL BLISTER; PETECHIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; TURNER SYNDROME;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 79961016619     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34741-7     Document Type: Article

References (30)

1. Gill K., Kelton J. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 2000, 37:275-289.
2. Provan D., Stasi R., Newland A., Blanchette V.S., Bolton-Maggs P., Bussel J.B., et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010, 115:168-186.
3. Cines D., Blanchette V. Immune thrombocytopenic purpura. N Engl J Med 2002, 346:995-1008.
4. Sukenik-Halevy R., Ellis M., Fejgin M. Management of immune thrombocytopenic purpura. Obstet Gynecol Surv 2008, 63:182-188.
5. Temprano K., Bandlamudi R., Moore T. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005, 35:112-121.
6. Brenner B., Guilburd J., Tatarsky I., Doron Y., Goldsher D. Spontaneous intracranial hemorrhage in immune thrombocytopenic purpura. Neurosurgery 1988, 22:761-764.
7. Lee M., Kim W. Intracranial hemorrhage associated with idiopathic thrombocytopenia purpura: report of seven patients and a meta-analysis. Neurology 1998, 50:1160-1163.
8. Kojouri K., Vesely S., Deirda T., George J.N. Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count response, prediction of response, and surgical complications. Blood 2004, 104:2623-2634.
9. Felbinger T., Posner M., Eltzschig H., Kodali B.S. Laparoscopic splenectomy in a pregnant patient with immune thrombocytopenic purpura. Int J Obstet Anesth 2007, 16:281-283.
10. Gottlieb P. Splenectomy during pregnancy: an option in the treatment of autoimmune thrombocytopenia. Br J Obstet Gynaecol 1999, 106:373-375.
11. Griffiths J., Sia W., Shapiro A., Tataryn I., Turner A.R. Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. J Obstet Gynaecol Can 2005, 27:771-774.
12. Iwase K., Higaki J., Yoon H., Mikata S., Tanaka Y., Takahashi T., et al. Hand-assisted laparoscopic splenectomy for idiopathic thrombocytopenic purpura during pregnancy. Surg Laparosc Endosc Percutan Tech 2001, 11:53-56.
13. Varghese L., Viswabandya A., Mathew A. Dapsone, danazol, and intrapartum splenectomy in refractory ITP complicating pregnancy. Indian J Med Sci 2008, 62:452-455.
14. Cerny T., Borisch B., Introna M., Johnson P., Rose A.L. Mechanism of action of rituximab. Anticancer Drugs 2002, 13(Suppl 2):S3-S10.
15. Arnold D., Dentali F., Crowther M., Meyer R.M., Cook R.J., Sigouin C., et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 2007, 146:25-33.
16. Godeau B., Porcher R., Fain O., Lefrère F., Fenaux P., Cheze S., et al. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood 2008, 112:999-1004.
17. Vinet E., Pineau C., Gordon C., Clarke A.E., Bernatsky S. Biologic therapy and pregnancy outcomes in women with rheumatic diseases. Arthritis Rheum 2009, 61:587-592.
18. Pellkofer H., Suessmair C., Schulze A., Hohlfeld R., Kuempfel T. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab. Mult Scler 2009, 15:1006-1008.
19. Klink D., van Eldburg R., Schreurs M., van Well G.T. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol 2008, 2008:271363.
20. Østensen M., Lockshin M., Doria A., Valesini G., Meroni P., Gordon C., et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology 2008, 47(Suppl 3):iii28-iii31.
21. Decker M., Rothermundt C., Hollander G., Tichelli A., Rochlitz C. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006, 7:693-694.
22. Carson K.R., Evens A.M., Richey E.A., Habermann T.M., Focosi D., Seymour J.F., et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009, 313:4834-4840.
23. Gheuens S., Pierone G., Peeters P., Koralnik I.J. Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 2010, 81:247-254.
24. Medeiros C., Marini S., Baptista M., Guerra G., Maciel-Guerra A.T. Turner's syndrome and thyroid disease: a transverse study of pediatric patients in Brazil. J Pediatr Endocrinol Metab 2000, 13:357-362.
25. Saenger P. Clinical manifestations and diagnosis of Turner syndrome (gonadal dysgenesis). UpToDate 2009. Available at: Accessed September 22, 2010. http://www.uptodate.com/patients/content/topic.do?topicKey=~AcBnBTibV5GCb1n.
26. Holtrop P. The frequency of hypoglycemia in full-term large and small for gestational age newborns. Am J Perinatol 1993, 10:150-154.
27. Sarici S., Serdar M., Korkmaz A., Erdem G., Oran O., Tekinalp G., et al. Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 2004, 113:775-780.
28. Modi N. Hyponatremia in the newborn. Arch Dis Child Fetal Neonatal Ed 1998, 78:F81-F84.
29. Roberts I., Stanworth S., Murray N. Thrombocytopenia in the neonate. Blood Rev 2008, 22:173-186.
30. Hohlfeld P., Forestier F., Kaplan C., Tissot J.D., Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samples. Blood 1994, 84:1851-1856.